← Back to headlines
PharmX Highlights 73% Marketplace Surge Amid Cost Pressures in FY26 Results
PharmX presented its FY26 financial slides showing a substantial 73 percent increase in marketplace activity, though elevated investment costs continue to weigh on overall EBITDA performance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Partners Group Replaces Chief Executive Amid Fund Redemption Pressures
40m ago
TCL Files Lawsuit Against Samsung Over Alleged False Advertising of Mini LED Televisions
42m ago
Trump Advocates Federal Tax Credits to Revitalize U.S. Film Industry
1h ago
Swiss Life Announces 600 Job Cuts Amid Digital Transformation Push
1h ago